Ranibizumab reimbursement and treatment patterns for neovascular age-related macular degeneration in Taiwan – Results from the 12-month, observational RENOWNED study

Chen S.-N.Lai C.-C.JIA-KANG WANGChoi H.-Y.Kuo C.-N.Tsai C.-Y.Wang H.-I.CHUNG-MAY YANG2022-07-152022-07-1520220929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126110656&doi=10.1016%2fj.jfma.2022.02.005&partnerID=40&md5=8d16211d0013c78aa1cde1de4fbc005ahttps://scholars.lib.ntu.edu.tw/handle/123456789/615229[SDGs]SDG3Ranibizumab reimbursement and treatment patterns for neovascular age-related macular degeneration in Taiwan – Results from the 12-month, observational RENOWNED studyjournal article10.1016/j.jfma.2022.02.0052-s2.0-85126110656